Log In | Register
NEW YORK — Pfizer Inc. said Thursday that William Ringo will retire as a senior vice president at the drug maker.
Ringo will be replaced April 30 by Kristin Peck, who will become senior vice president of worldwide business development, strategy and innovation.
Ringo has held that post at New York-based Pfizer since April 2008, after he retired from Eli Lilly & Co. following 28 years with the Indianapolis company. Between his appointments at Lilly and Pfizer, Ringo served in leadership roles at venture capital and biotechnology companies. He has spent more than four decades in the pharmaceutical industry.
Peck joined Pfizer in 2004 in the company's strategic planning organization. Most recently, she played a leading role in the integration of Wyeth, which Pfizer bought in October.
In her new role, Peck will report directly to Pfizer Chairman and CEO Jeff Kindler.
